I'm not cutting down the company, just saying caution is warranted. And no, Fuse does not have anywhere near that many out, as the total authorized is 400mil and looks like in the neighborhood of 300mil out now. Problem?, maybe....workable? Only if sales take off and we'll see soon on that....
You realize that they are now non-reporting, so you will be completely in the dark on financials and dilution?? No thanks!!!! Good luck with that, you'll need it.
Good luck with that, but the promotion doesn't belong on this board... I wouldn't buy Fuse if they just had PowerFuse and I certainly wouldn't go running to PHLI on this one product, but I hope it works for you!
That would be like investing in Fuse just on Powerfuse alone....no thanks... You gotta like the capital structure much better though...good luck!
Right...a non-business that did over $10mil in revenues last year and just had an independent study verify the effectiveness of their product...Nice try. Maybe do some real DD next time.
You ignorant fool...you think you are smart but you are not---YOU are the one with all the aliases on here---not me...I'm no insider--far, far from it. I'm also not telling anyone to buy---just giving my opinion. Your motives here are FAR more suspect!!!!! Unlike you, I've done proper DD....
Wow, you must be Super -trader as it touched the high for a very brief second today. I sure wouldn't want to be out though after the Macular news and the call coming tomorrow
You are lost on this one you fool.... The Alabama Business Journal article was on an independent study on Macular Health's product that they are now enhancing with Fuse's technology and the quotes are from the CEO of Macular. You are a buffoon !!! The truth wins out every time....
This past August, Macular Health struck a partnership with Fuse Science Inc., a publicly traded company that produces nutritional supplements for athletes. Professional golfer Tiger Woods is a shareholder in Fuse, McAnnally said.
The partnership has Fuse take Macular Health's capsule formula and convert it for use in an oral dropper. McAnnally said the dropper with Macular Health's product is slated to hit the market this coming October.The study paves the way for a bigger relationship between Macular Health and Fuse, McAnnally said.
"Financially, it's going to have a huge impact on our company and Fuse," he said. "Their (Fuse) stock is going to soar."
Yeah, tomorrow is a non-event as far as sales go...no way it sends the stock to .20.....unless there is something huge in addition....not likely
Yeah, just a couple days ago this was a "shell" according to him... I wouldn't believe a word he says---good or bad!!